University of Surrey

[1]  Stephen E. Fienberg,et al.  Testing Statistical Hypotheses , 2005 .

[2]  R. Bianchi,et al.  Burnout-depression overlap: Nomological network examination and factor-analytic approach. , 2018, Scandinavian journal of psychology.

[3]  Polymnia Georgiou,et al.  Oxytocin and opioid addiction revisited: old drug, new applications , 2018, British journal of pharmacology.

[4]  M. Griffiths,et al.  The Development of the Problematic Pornography Consumption Scale (PPCS) , 2018, Journal of sex research.

[5]  I. Neumann,et al.  Rebalancing the Addicted Brain: Oxytocin Interference with the Neural Substrates of Addiction , 2017, Trends in Neurosciences.

[6]  Matthew W. Johnson,et al.  Morning administration of oral methamphetamine dose-dependently disrupts nighttime sleep in recreational stimulant users. , 2017, Drug and alcohol dependence.

[7]  T. George,et al.  Management of mood and anxiety disorders in patients receiving opioid agonist therapy: Review and meta‐analysis , 2017, The American journal on addictions.

[8]  Danielle M. Morabito,et al.  Cannabis, Cannabinoids, and Sleep: a Review of the Literature , 2017, Current Psychiatry Reports.

[9]  Aline Romani-Sponchiado,et al.  Theory of Mind in Substance Users: A Systematic Minireview , 2017, Substance use & misuse.

[10]  Rose A Rudd,et al.  Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015. , 2016, MMWR. Morbidity and mortality weekly report.

[11]  David J. Barker,et al.  VTA glutamatergic inputs to nucleus accumbens drive aversion by acting on GABAergic interneurons , 2016, Nature Neuroscience.

[12]  R. Stackman,et al.  Activation of serotonin 5-HT2C receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice , 2016, Neuropharmacology.

[13]  M. Packard,et al.  Memory Systems and the Addicted Brain , 2016, Front. Psychiatry.

[14]  G. Leng,et al.  Intranasal Oxytocin: Myths and Delusions , 2016, Biological Psychiatry.

[15]  G. Bedi,et al.  The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals , 2015, Neuroscience & Biobehavioral Reviews.

[16]  K. Brady,et al.  Effects of adverse childhood experiences on the association between intranasal oxytocin and social stress reactivity among individuals with cocaine dependence , 2015, Psychiatry Research.

[17]  D. Slattery,et al.  Oxytocin Regulates Stress-Induced Crf Gene Transcription through CREB-Regulated Transcription Coactivator 3 , 2015, The Journal of Neuroscience.

[18]  Andrea Galeotti,et al.  Diffusion and protection across a random graph , 2015, Network Science.

[19]  R. Wightman,et al.  Differential Dopamine Release Dynamics in the Nucleus Accumbens Core and Shell Reveal Complementary Signals for Error Prediction and Incentive Motivation , 2015, The Journal of Neuroscience.

[20]  L. Sanford,et al.  Effects of corticotropin releasing factor (CRF) on sleep and temperature following predictable controllable and uncontrollable stress in mice , 2015, Front. Neurosci..

[21]  Polymnia Georgiou,et al.  Region-specific up-regulation of oxytocin receptor binding in the brain of mice following chronic nicotine administration , 2015, Neuroscience Letters.

[22]  Min Zhao,et al.  Efficacy of Cognitive Behavioral Therapy on Opiate Use and Retention in Methadone Maintenance Treatment in China: A Randomised Trial , 2015, PloS one.

[23]  M. Frye,et al.  Female smokers have the highest alcohol craving in a residential alcoholism treatment cohort. , 2015, Drug and alcohol dependence.

[24]  R. McHugh,et al.  Treatment of Co-occurring Anxiety Disorders and Substance Use Disorders , 2015, Harvard review of psychiatry.

[25]  B. Hyland,et al.  Oxytocin enhances the expression of morphine-induced conditioned place preference in rats , 2015, Psychoneuroendocrinology.

[26]  J. Larson,et al.  An Inquiry into the Nature and Causes of the Wealth of Nations , 2015 .

[27]  M. Greene,et al.  Do Drug-Dependent Patients Attending Alcoholics Anonymous Rather than Narcotics Anonymous Do As Well? A Prospective, Lagged, Matching Analysis. , 2014, Alcohol and alcoholism.

[28]  A. Håkansson,et al.  Predictors of Dropout from Inpatient Opioid Detoxification with Buprenorphine: A Chart Review , 2014, Journal of addiction.

[29]  Zuoxin Wang,et al.  Hypothalamic Oxytocin Mediates Social Buffering of the Stress Response , 2014, Biological Psychiatry.

[30]  I. Liberzon,et al.  Translational Implications of Oxytocin-Mediated Social Buffering Following Immobilization Stress in Female Prairie Voles , 2014, Biological Psychiatry.

[31]  Rosa L. Matzkin,et al.  Control functions in nonseparable simultaneous equations models , 2014 .

[32]  D. Filliol,et al.  Distinct Mu, Delta, and Kappa Opioid Receptor Mechanisms Underlie Low Sociability and Depressive-Like Behaviors During Heroin Abstinence , 2014, Neuropsychopharmacology.

[33]  Yue Zhao,et al.  Effect of cognitive behavioural interventions on the quality of life in Chinese heroin-dependent individuals in detoxification: a randomised controlled trial. , 2014, Journal of clinical nursing.

[34]  G. Koob,et al.  Corticotropin releasing factor: A key role in the neurobiology of addiction , 2014, Frontiers in Neuroendocrinology.

[35]  D. Slattery,et al.  Dose-dependent effects of chronic central infusion of oxytocin on anxiety, oxytocin receptor binding and stress-related parameters in mice , 2014, Psychoneuroendocrinology.

[36]  Polymnia Georgiou,et al.  The Oxytocin Analogue Carbetocin Prevents Emotional Impairment and Stress-Induced Reinstatement of Opioid-Seeking in Morphine-Abstinent Mice , 2014, Neuropsychopharmacology.

[37]  R. Rosenheck,et al.  Psychiatric correlates of past incarceration in the national co-morbidity study replication. , 2014, Criminal behaviour and mental health : CBMH.

[38]  C. Campbell,et al.  A Double Blind, within Subject Comparison of Spontaneous Opioid Withdrawal from Buprenorphine versus Morphine , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[39]  G. Wallen,et al.  Sleep Disturbances in Individuals with Alcohol-Related Disorders: A Review of Cognitive-Behavioral Therapy for Insomnia (CBT-I) and Associated Non-Pharmacological Therapies , 2014, Substance abuse : research and treatment.

[40]  Justin M. Rao,et al.  Ideological Segregation and the Effects of Social Media on News Consumption , 2013 .

[41]  T. Lloyd,et al.  Testing the trilemma: exchange rate regimes, capital mobility, and monetary independence , 2013 .

[42]  G. Andersson,et al.  A Meta-Analysis of Cognitive-Behavioural Therapy for Adult Depression, Alone and in Comparison with other Treatments , 2013, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[43]  Simon Baron-Cohen,et al.  The “Reading the Mind in the Eyes” test: Systematic review of psychometric properties and a validation study in Italy , 2013, Cognitive neuropsychiatry.

[44]  K. Brady,et al.  Effect of oxytocin on craving and stress response in marijuana-dependent individuals: a pilot study , 2013, Psychopharmacology.

[45]  N. Petry,et al.  Contingency management treatments decrease psychiatric symptoms. , 2013, Journal of consulting and clinical psychology.

[46]  Zhi-jian Zhang,et al.  The interaction between the oxytocin and pain modulation in headache patients , 2013, Neuropeptides.

[47]  W. Sanefuji,et al.  Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders. , 2013, Journal of child and adolescent psychopharmacology.

[48]  H. Popper,et al.  Trilemma Stability and International Macroeconomic Archetypes , 2013 .

[49]  J. Aizenman.  THE IMPOSSIBLE TRINITY — FROM THE POLICY TRILEMMA TO THE POLICY QUADRILEMMA , 2013 .

[50]  S. McDonald,et al.  Deficits in social perception in opioid maintenance patients, abstinent opioid users and non-opioid users. , 2013, Addiction.

[51]  L. Jarskog,et al.  Intranasal oxytocin blocks alcohol withdrawal in human subjects. , 2013, Alcoholism, clinical and experimental research.

[52]  R. Moos,et al.  Dually diagnosed patients' benefits of mutual-help groups and the role of social anxiety. , 2013, Journal of substance abuse treatment.

[53]  Kathy Li,et al.  Mental disorder, service use, and barriers to care among 500 homeless people in 3 different urban settings , 2013, Social Psychiatry and Psychiatric Epidemiology.

[54]  L. Soorya,et al.  Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial , 2012, Molecular Autism.

[55]  J. Rybakowski,et al.  [The role of oxytocin and vasopressin in central nervous system activity and mental disorders]. , 2012, Psychiatria polska.

[56]  M. Mundt,et al.  12-Step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. , 2012, Drug and alcohol dependence.

[57]  K. Fuxe,et al.  On the role of volume transmission and receptor–receptor interactions in social behaviour: Focus on central catecholamine and oxytocin neurons , 2012, Brain Research.

[58]  R. Schultz,et al.  Oxytocin plasma concentrations after single intranasal oxytocin administration – A study in healthy men , 2012, Neuropeptides.

[59]  Orna Zagoory-Sharon,et al.  Intranasal oxytocin administration is reflected in human saliva , 2012, Psychoneuroendocrinology.

[60]  Jamie Peters,et al.  Glutamate mechanisms underlying opiate memories. , 2012, Cold Spring Harbor perspectives in medicine.

[61]  Christos Faloutsos,et al.  Interacting viruses in networks: can both survive? , 2012, KDD.

[62]  M. Angstadt,et al.  Medial frontal hyperactivity to sad faces in generalized social anxiety disorder and modulation by oxytocin. , 2012, The international journal of neuropsychopharmacology.

[63]  F. Carmignani,et al.  Introduction to Modern Economic Growth. , 2012 .

[64]  M. Chinn,et al.  The 'Impossible Trinity' Hypothesis in an Era of Global Imbalances: Measurement and Testing , 2012 .

[65]  J. Tiihonen,et al.  Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial. , 2012, The American journal of psychiatry.

[66]  D. Slattery,et al.  Central administration of oxytocin receptor ligands affects cued fear extinction in rats and mice in a timepoint-dependent manner , 2012, Psychopharmacology.

[67]  Christos Faloutsos,et al.  Winner takes all: competing viruses or ideas on fair-play networks , 2012, WWW.

[68]  K. J. Parker,et al.  Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome , 2012, Psychoneuroendocrinology.

[69]  J. Steiner,et al.  Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors , 2012, Addiction Science & Clinical Practice.

[70]  E. Palazidou.  The neurobiology of depression. , 2012, British medical bulletin.

[71]  I. McGregor,et al.  Breaking the loop: Oxytocin as a potential treatment for drug addiction , 2012, Hormones and Behavior.

[72]  C. MacLeod,et al.  A critical review of the influence of oxytocin nasal spray on social cognition in humans: Evidence and future directions , 2012, Hormones and Behavior.

[73]  Mark D. Griffiths,et al.  Internet sex addiction: A review of empirical research , 2012 .

[74]  B. Golub,et al.  How Homophily Affects the Speed of Learning and Best Response Dynamics , 2012 .

[75]  S. Kasper,et al.  Actigraphic Measurements in Opioid Detoxification With Methadone or Buprenorphine , 2012, Journal of clinical psychopharmacology.

[76]  Matthew O. Jackson,et al.  Diffusion and contagion in networks with heterogeneous agents and homophily , 2011, Network Science.

[77]  Michael Kearns,et al.  Competitive contagion in networks , 2011, STOC '12.

[78]  G. Aston-Jones,et al.  α2 Adrenergic and Imidazoline Receptor Agonists Prevent Cue-Induced Cocaine Seeking , 2011, Biological Psychiatry.

[79]  Keith M. Kendrick,et al.  Prosocial effects of oxytocin and clinical evidence for its therapeutic potential , 2011, Frontiers in Neuroendocrinology.

[80]  K. Bentley,et al.  Treatment of Major Depressive Disorder and Dysthymic Disorder With Antidepressants in Patients With Comorbid Opiate Use Disorders Enrolled in Methadone Maintenance Therapy: A Meta-Analysis , 2011, Journal of clinical psychopharmacology.

[81]  N. Ronel,et al.  Can a 12-Step Program Work in Methadone Maintenance Treatment? , 2011, International journal of offender therapy and comparative criminology.

[82]  D. Slattery,et al.  The Neuropeptide Oxytocin Facilitates Pro-Social Behavior and Prevents Social Avoidance in Rats and Mice , 2011, Neuropsychopharmacology.

[83]  R. Sinha,et al.  Effects of adrenal sensitivity, stress- and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes. , 2011, Archives of general psychiatry.

[84]  Florence Levy,et al.  A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research , 2011, Psychoneuroendocrinology.

[85]  Peter Kirsch,et al.  Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine , 2011, Nature Reviews Neuroscience.

[86]  Alessandra Lintas,et al.  Identification of a Dopamine Receptor-Mediated Opiate Reward Memory Switch in the Basolateral Amygdala–Nucleus Accumbens Circuit , 2011, The Journal of Neuroscience.

[87]  Matthew C Grissinger,et al.  Keeping patients safe from methadone overdoses. , 2011, P & T : a peer-reviewed journal for formulary management.

[88]  A. Sadeh.  The role and validity of actigraphy in sleep medicine: an update. , 2011, Sleep medicine reviews.

[89]  C. Robinet,et al.  Oxytocin Selectively Gates Fear Responses Through Distinct Outputs from the Central Amygdala , 2011, Science.

[90]  Axel Schäfer,et al.  Localized gray matter volume abnormalities in generalized anxiety disorder , 2011, European Archives of Psychiatry and Clinical Neuroscience.

[91]  Z. Sarnyai.  Oxytocin as a potential mediator and modulator of drug addiction , 2011, Addiction biology.

[92]  J. Broadbear,et al.  Examining the role of oxytocin in the interoceptive effects of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) using a drug discrimination paradigm in the rat , 2011, Addiction biology.

[93]  D. Popovic,et al.  Dual Diagnosis and Chronology of Illness in Treatment-Seeking Italian Patients Dependent on Heroin , 2011, Journal of addictive diseases.

[94]  Paul E. Croarkin,et al.  Psychomotor retardation in depression: Biological underpinnings, measurement, and treatment , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[95]  N. Volkow,et al.  Addiction: Beyond dopamine reward circuitry , 2011, Proceedings of the National Academy of Sciences.

[96]  Philip A. Haile,et al.  Identification in a Class of Nonparametric Simultaneous Equations Models , 2011 .

[97]  Dieter Henkel,et al.  Unemployment and substance use: a review of the literature (1990-2010). , 2011, Current drug abuse reviews.

[98]  B. Kieffer,et al.  Impaired Emotional-Like Behavior and Serotonergic Function During Protracted Abstinence from Chronic Morphine , 2011, Biological Psychiatry.

[99]  Kimberly A. Young,et al.  Neuroscience and Biobehavioral Reviews the Role of Mesocorticolimbic Dopamine in Regulating Interactions between Drugs of Abuse and Social Behavior , 2022 .

[100]  M. Torrens,et al.  Psychiatric comorbidity in illicit drug users: substance-induced versus independent disorders. , 2011, Drug and alcohol dependence.

[101]  S. Strobbe,et al.  How Alcoholics Anonymous (AA) and Narcotics Anonymous (NA) Work: Cross-Disciplinary Perspectives , 2011, Alcoholism treatment quarterly.

[102]  Allan Borodin,et al.  Threshold Models for Competitive Influence in Social Networks , 2010, WINE.

[103]  L. Amato,et al.  Pharmacological treatment for depression during opioid agonist treatment for opioid dependence. , 2010, The Cochrane database of systematic reviews.

[104]  M. Otto,et al.  Cognitive behavioral therapy for substance use disorders. , 2010, The Psychiatric clinics of North America.

[105]  A. Dreher,et al.  When is a central bank governor replaced? Evidence based on a new data set , 2010 .

[106]  Pradeep J Nathan,et al.  Oxytocin Attenuates Amygdala Reactivity to Fear in Generalized Social Anxiety Disorder , 2010, Neuropsychopharmacology.

[107]  J. Zohar,et al.  Hippocampal Microinfusion of Oxytocin Attenuates the Behavioural Response to Stress by Means of Dynamic Interplay with the Glucocorticoid‐Catecholamine Responses , 2010, Journal of neuroendocrinology.

[108]  M. Lambert,et al.  The dose response relationship in psychotherapy: Implications for social policy , 2010 .

[109]  Murray B Stein,et al.  The pharmacologic treatment of anxiety disorders: a review of progress. , 2010, The Journal of clinical psychiatry.

[110]  M. Chinn,et al.  The emerging global financial architecture: Tracing and evaluating new patterns of the trilemma configuration , 2010 .

[111]  Michael X. Cohen,et al.  Oxytocin Enhances Amygdala-Dependent, Socially Reinforced Learning and Emotional Empathy in Humans , 2010, The Journal of Neuroscience.

[112]  Jesse M. Shapiro,et al.  Ideological Segregation Online and Offline , 2010 .

[113]  S. Sussman.  A Review of Alcoholics Anonymous/ Narcotics Anonymous Programs for Teens , 2010, Evaluation & the health professions.

[114]  D. Pine,et al.  Oxytocin improves specific recognition of positive facial expressions , 2010, Psychopharmacology.

[115]  E. V. Bockstaele,et al.  The locus coeruleus: A key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse , 2010, Brain Research.

[116]  Angela Sirigu,et al.  Promoting social behavior with oxytocin in high-functioning autism spectrum disorders , 2010, Proceedings of the National Academy of Sciences.

[117]  G. Hulse.  Subcutaneous naltrexone implants reduce opioid use in opiate dependent patients , 2010, Evidence-Based Mental Health.

[118]  D. Slattery,et al.  Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats , 2010, Neuropharmacology.

[119]  N. Petry,et al.  Methadone Deaths: Risk Factors in Pain and Addicted Populations , 2010, Journal of General Internal Medicine.

[120]  K. Macdonald,et al.  The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. , 2010, Harvard review of psychiatry.

[121]  Shelley E. Taylor,et al.  Are Plasma Oxytocin in Women and Plasma Vasopressin in Men Biomarkers of Distressed Pair-Bond Relationships? , 2010, Psychological science.

[122]  K. Arrow,et al.  *Conspicuous Consumption, Inconspicuous Leisure , 2009 .

[123]  E. Eşel,et al.  Serum oxytocin levels in patients with depression and the effects of gender and antidepressant treatment , 2009, Psychiatry Research.

[124]  F. Talih,et al.  Sleep disorders in substance abusers: how common are they? , 2009, Psychiatry (Edgmont (Pa. : Township)).

[125]  B. Starfield,et al.  Defining Comorbidity: Implications for Understanding Health and Health Services , 2009, The Annals of Family Medicine.

[126]  P. Randall,et al.  Social anxiety impacts willingness to participate in addiction treatment. , 2009, Addictive behaviors.

[127]  I. Kant,et al.  Idea for a Universal History with a Cosmopolitan Aim , 2009 .

[128]  L. Kaskutas,et al.  Please Scroll down for Article Journal of Addictive Diseases Alcoholics Anonymous Effectiveness: Faith Meets Science Alcoholics Anonymous Effectiveness: Faith Meets Science , 2022 .

[129]  D. Hasin,et al.  Dimensionality of lifetime alcohol abuse, dependence and binge drinking. , 2009, Drug and alcohol dependence.

[130]  Ronald C Kessler,et al.  The global burden of mental disorders: An update from the WHO World Mental Health (WMH) Surveys* , 2009, Epidemiologia e Psichiatria Sociale.

[131]  K. Witkiewitz,et al.  Marriage and relationship closeness as predictors of cocaine and heroin use. , 2009, Addictive behaviors.

[132]  Tadashi Kimura,et al.  Evidence That Oxytocin Exerts Anxiolytic Effects via Oxytocin Receptor Expressed in Serotonergic Neurons in Mice , 2009, The Journal of Neuroscience.

[133]  J. W. Aldridge,et al.  Dissecting components of reward: 'liking', 'wanting', and learning. , 2009, Current opinion in pharmacology.

[134]  Alpo Willman,et al.  Identifying the Elasticity of Substitution with Biased Technical Change , 2009, SSRN Electronic Journal.

[135]  Matthew O. Jackson,et al.  Average Distance, Diameter, and Clustering in Social Networks with Homophily , 2008, WINE.

[136]  D. Riemann,et al.  Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana. , 2008, Sleep medicine reviews.

[137]  Rajita Sinha,et al.  Chronic Stress, Drug Use, and Vulnerability to Addiction , 2008, Annals of the New York Academy of Sciences.

[138]  L. Bierut,et al.  The prognostic implications of DSM-IV abuse criteria in drinking adolescents. , 2008, Drug and Alcohol Dependence.

[139]  Rosa L. Matzkin.  Identification in Nonparametric Simultaneous Equations Models , 2008 .

[140]  Leeat Yariv,et al.  Similarity and Polarization in Groups , 2008 .

[141]  Tammy Chung,et al.  How should we revise diagnostic criteria for substance use disorders in the DSM-V? , 2008, Journal of abnormal psychology.

[142]  I. McGregor,et al.  From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long‐term adverse consequences of drug use? , 2008, British journal of pharmacology.

[143]  A. Schulz,et al.  Post-learning intranasal oxytocin modulates human memory for facial identity , 2008, Psychoneuroendocrinology.

[144]  D. Slattery,et al.  No stress please! Mechanisms of stress hyporesponsiveness of the maternal brain , 2008, The Journal of physiology.

[145]  Philip B. Mitchell,et al.  Oxytocin Increases Gaze to the Eye Region of Human Faces , 2008, Biological Psychiatry.

[146]  M. Torrens,et al.  Impact of Substance Dependence and Dual Diagnosis on the Quality of Life of Heroin Users Seeking Treatment , 2008, Substance use & misuse.

[147]  G. Treisman,et al.  Medical Consequences of Drug Abuse and Co-Occurring Infections , 2008, Substance abuse.

[148]  A. Waterman.  Mathematical Modeling as an Exegetical Tool: Rational Reconstruction , 2007 .

[149]  Shishir Bharathi,et al.  Competitive Influence Maximization in Social Networks , 2007, WINE.

[150]  Brady T. West,et al.  Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. , 2007, Addiction.

[151]  A. Nichols,et al.  Clustered standard errors in Stata , 2007 .

[152]  Enno Mammen,et al.  Identification of marginal effects in nonseparable models without monotonicity , 2007 .

[153]  G. Koob,et al.  A key role for corticotropin-releasing factor in alcohol dependence , 2007, Trends in Neurosciences.

[154]  B. Samoliński,et al.  Changes in Nasal Cavity Dimensions in Children and Adults by Gender and Age , 2007, The Laryngoscope.

[155]  Victor Chernozhukov,et al.  Instrumental variable estimation of nonseparable models , 2007 .

[156]  P. Vaglum,et al.  Axis I and II disorders as long-term predictors of mental distress: a six-year prospective follow-up of substance-dependent patients , 2007, BMC psychiatry.

[157]  I. McGregor,et al.  A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine (“ecstasy”) , 2007, Neuroscience.

[158]  G. Koob,et al.  Drug addiction: Pathways to the disease and pathophysiological perspectives , 2007, European Neuropsychopharmacology.

[159]  W. Yung,et al.  Serotonin increases the excitability of the hypothalamic paraventricular nucleus magnocellular neurons , 2007, The European journal of neuroscience.

[160]  Li-yan Zhao,et al.  Long-term methadone maintenance reduces protracted symptoms of heroin abstinence and cue-induced craving in Chinese heroin abusers , 2007, Pharmacology Biochemistry and Behavior.

[161]  Danielle E. Ramo,et al.  Substance use treatment outcomes for youth: integrating personal and environmental predictors. , 2007, Drug and alcohol dependence.

[162]  I. Neumann.  Oxytocin: the neuropeptide of love reveals some of its secrets. , 2007, Cell metabolism.

[163]  A. Agrawal,et al.  Psychometric properties of DSM assessments of illicit drug abuse and dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) , 2007, Psychological Medicine.

[164]  S. Schreiber,et al.  Depression in methadone maintenance treatment patients: rate and risk factors. , 2007, Journal of affective disorders.

[165]  R. Sinha,et al.  Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment. , 2007, Experimental and clinical psychopharmacology.

[166]  M. Connock,et al.  Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. , 2007, Health technology assessment.

[167]  M. Heinrichs,et al.  Neuroendocrine mechanisms of stress and social interaction: implications for mental disorders , 2007, Current opinion in psychiatry.

[168]  Yih-Ing Hser,et al.  Predicting Long-Term Stable Recovery from Heroin Addiction , 2007, Journal of addictive diseases.

[169]  Robert M. Solow,et al.  The last 50 years in growth theory and the next 10 , 2007 .

[170]  Matthew O. Jackson,et al.  Relating Network Structure to Diffusion Properties through Stochastic Dominance , 2007 .

[171]  Evdokia Anagnostou,et al.  Oxytocin Increases Retention of Social Cognition in Autism , 2007, Biological Psychiatry.

[172]  D. Swaab,et al.  Hypothalamic oxytocin mRNA expression and melancholic depression , 2007, Molecular Psychiatry.

[173]  A. Heath,et al.  The role of childhood risk factors in initiation of alcohol use and progression to alcohol dependence. , 2007, Addiction.

[174]  C. Carter,et al.  Sex differences in oxytocin and vasopressin: Implications for autism spectrum disorders? , 2007, Behavioural Brain Research.

[175]  J. Ferrari,et al.  Friends, family, and alcohol abuse: an examination of general and alcohol-specific social support. , 2007, The American journal on addictions.

[176]  R. C. Pierce,et al.  The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse? , 2006, Neuroscience & Biobehavioral Reviews.

[177]  Pradeep Dubey,et al.  Competing for Customers in a Social Network: The Quasi-linear Case , 2006, WINE.

[178]  N. Volkow,et al.  Drug addiction: the neurobiology of disrupted self-control. , 2006, Trends in molecular medicine.

[179]  T. Roth,et al.  The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. , 2006, Journal of psychiatric research.

[180]  I. Figueira,et al.  Social anxiety disorder in 300 patients hospitalized for alcoholism in Brazil: high prevalence and undertreatment. , 2006, Comprehensive psychiatry.

[181]  J. Sareen,et al.  Lifetime mood, anxiety, and drug use disorders are common in the United States population , 2006, Evidence-based mental health.

[182]  P. Rucci,et al.  A relationship between oxytocin and anxiety of romantic attachment , 2006, Clinical practice and epidemiology in mental health : CP & EMH.

[183]  Kenneth S. Rogoff,et al.  Financial Globalization: A Reappraisal , 2006, SSRN Electronic Journal.

[184]  N. Volkow,et al.  Cocaine Cues and Dopamine in Dorsal Striatum: Mechanism of Craving in Cocaine Addiction , 2006, The Journal of Neuroscience.

[185]  Philippe Aghion,et al.  Exchange Rate Volatility and Productivity Growth: The Role of Financial Development , 2006 .

[186]  K. Walitzer,et al.  Gender differences in alcohol and substance use relapse. , 2006, Clinical psychology review.

[187]  P. Stasiewicz,et al.  Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: a review. , 2006, Clinical psychology review.

[188]  R. Layard.  *Happiness and Public Policy: A Challenge to the Profession , 2006 .

[189]  Wilson Compton,et al.  Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. , 2006, The Journal of clinical psychiatry.

[190]  D. Kupfer,et al.  Presenting characteristics of depressed outpatients as a function of recurrence: preliminary findings from the STAR*D clinical trial. , 2006, Journal of psychiatric research.

[191]  M. Bogenschutz,et al.  The role of twelve-step approaches in dual diagnosis treatment and recovery. , 2006, The American journal on addictions.

[192]  Eman Hassan,et al.  Recall Bias can be a Threat to Retrospective and Prospective Research Designs , 2005 .

[193]  Peter Kirsch,et al.  Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans , 2005, The Journal of Neuroscience.

[194]  K. Brady,et al.  Mood Disorders and Substance Use Disorder: A Complex Comorbidity , 2005, Science & practice perspectives.

[195]  E. Nestler.  Is there a common molecular pathway for addiction? , 2005, Nature Neuroscience.

[196]  C. Lyketsos,et al.  Mood Disorders in the Medically Ill: Scientific Review and Recommendations , 2005, Biological Psychiatry.

[197]  K. Brady,et al.  Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. , 2005, The American journal of psychiatry.

[198]  B. Grant,et al.  Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. , 2005, The Journal of clinical psychiatry.

[199]  G. Martinotti,et al.  Anhedonia and Substance-Related Symptoms in Detoxified Substance-Dependent Subjects: A Correlation Study , 2005, Neuropsychobiology.

[200]  M. Keller,et al.  Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. , 2005, The American journal of psychiatry.

[201]  Olga V. Demler,et al.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[202]  Rajita Sinha,et al.  Stress enhancement of craving during sobriety: a risk for relapse. , 2005, Alcoholism, clinical and experimental research.

[203]  M. Chinn,et al.  What Matters for Financial Development? Capital Controls, Institutions, and Interactions , 2005 .

[204]  Colin H. Brown,et al.  Morphine withdrawal increases intrinsic excitability of oxytocin neurons in morphine‐dependent rats , 2005, European Journal of Neuroscience.

[205]  K. Kendrick.  The Neurobiology of Social Bonds , 2004, Journal of neuroendocrinology.

[206]  Nora D. Volkow,et al.  The reality of comorbidity: Depression and drug abuse , 2004, Biological Psychiatry.

[207]  M. Mobius,et al.  Getting Closer or Drifting Apart , 2004 .

[208]  P. Howitt,et al.  Competition and Innovation: an Inverted-U Relationship , 2005 .

[209]  A. Brooks,et al.  The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trial. , 2004, Drug and alcohol dependence.

[210]  S. Wei,et al.  Does Financial Globalization Induce Better Macroeconomic Policies? , 2004, SSRN Electronic Journal.

[211]  M. Bussière,et al.  Financial Openness and Growth: Short-Run Gain, Long-Run Pain? , 2004 .

[212]  Peter Sheridan Dodds,et al.  Universal behavior in a generalized model of contagion. , 2004, Physical review letters.

[213]  S. Lightman,et al.  Oxytocin Attenuates Stress-Induced c-fos mRNA Expression in Specific Forebrain Regions Associated with Modulation of Hypothalamo–Pituitary–Adrenal Activity , 2004, The Journal of Neuroscience.

[214]  Alan M. Taylor,et al.  The Trilemma in History: Tradeoffs Among Exchange Rates, Monetary Policies, and Capital Mobility , 2004, Review of Economics and Statistics.

[215]  Jay C. Shambaugh.  The Effect of Fixed Exchange Rates on Monetary Policy , 2004 .

[216]  C. Kirschbaum,et al.  Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress , 2003, Biological Psychiatry.

[217]  T. Onaka,et al.  Facilitative role of endogenous oxytocin in noradrenaline release in the rat supraoptic nucleus , 2003, The European journal of neuroscience.

[218]  N. Zisapel,et al.  Cross‐cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients , 2003, Human psychopharmacology.

[219]  G. Schulteis,et al.  Repeated experience with naloxone facilitates acute morphine withdrawal: potential role for conditioning processes in acute opioid dependence , 2003, Pharmacology Biochemistry and Behavior.

[220]  R. Shen.  Ethanol Withdrawal Reduces the Number of Spontaneously Active Ventral Tegmental Area Dopamine Neurons in Conscious Animals , 2003, Journal of Pharmacology and Experimental Therapeutics.

[221]  W. Newey,et al.  Instrumental variable estimation of nonparametric models , 2003 .

[222]  T. Randell,et al.  Serious overdoses involving buprenorphine in Helsinki , 2003, Acta anaesthesiologica Scandinavica.

[223]  A. Chesher.  Identification in Nonseparable Models , 2003 .

[224]  Rosa L. Matzkin.  Nonparametric Estimation of Nonadditive Random Functions , 2003 .

[225]  T. Insel.  Is social attachment an addictive disorder? , 2003, Physiology & Behavior.

[226]  Y. Shaham,et al.  The reinstatement model of drug relapse: history, methodology and major findings , 2003, Psychopharmacology.

[227]  E. Coccaro,et al.  Plasma oxytocin in response to pharmaco-challenge to d-fenfluramine and placebo in healthy men , 2003, Psychiatry Research.

[228]  C. Carter,et al.  Hormonal regulation of agonistic and affiliative behavior in female mongolian gerbils (Meriones unguiculatus) , 2003, Hormones and Behavior.

[229]  R. Moos,et al.  Major depression in patients with substance use disorders: relationship to 12-Step self-help involvement and substance use outcomes. , 2003, Addiction.

[230]  L. Bierut,et al.  Five-year clinical course associated with DSM-IV alcohol abuse or dependence in a large group of men and women. , 2003, The American journal of psychiatry.

[231]  A. Kjaer,et al.  Serotonin Receptors Involved in Vasopressin and Oxytocin Secretion , 2003, Journal of neuroendocrinology.

[232]  M. Heilig,et al.  1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial , 2003, The Lancet.

[233]  F. Baud,et al.  Flunitrazepam variably alters morphine, buprenorphine, and methadone lethality in the rat , 2002, Human & experimental toxicology.

[234]  G. Imbens,et al.  Identification and Estimation of Triangular Simultaneous Equations Models without Additivity , 2002 .

[235]  J. Marsden,et al.  Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses. , 2002, Addiction.

[236]  P. Kintz.  A new series of 13 buprenorphine-related deaths. , 2002, Clinical biochemistry.

[237]  K. Wolff.  Characterization of Methadone Overdose: Clinical Considerations and the Scientific Evidence , 2002, Therapeutic drug monitoring.

[238]  T. George,et al.  The Neurobiology of Opioid Dependence: Implications for Treatment , 2002, Science & practice perspectives.

[239]  C. Brewer.  Serum naltrexone and 6‐beta‐naltrexol levels from naltrexone implants can block very large amounts of heroin: a report of two cases , 2002, Addiction biology.

[240]  R. Maldonado,et al.  Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinol , 2002, Psychopharmacology.

[241]  Jan Born,et al.  Sniffing neuropeptides: a transnasal approach to the human brain , 2002, Nature Neuroscience.

[242]  Duncan J Watts,et al.  A simple model of global cascades on random networks , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[243]  W. Miller,et al.  Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. , 2002, Addiction.

[244]  M. Greenwald.  Heroin craving and drug use in opioid-maintained volunteers: effects of methadone dose variations. , 2002, Experimental and clinical psychopharmacology.

[245]  P. Corrigan,et al.  Understanding the impact of stigma on people with mental illness. , 2002, World psychiatry : official journal of the World Psychiatric Association.

[246]  R. Longabaugh,et al.  Decomposing the relationships between pretreatment social network characteristics and alcohol treatment outcome. , 2002, Journal of studies on alcohol.

[247]  B. Grant,et al.  Age at onset of alcohol use and DSM-IV alcohol abuse and dependence: a 12-year follow-up. , 2001, Journal of substance abuse.

[248]  Dan J Stein,et al.  Hypersexual disorder and preoccupation with internet pornography. , 2001, The American journal of psychiatry.

[249]  M. McPherson,et al.  Birds of a Feather: Homophily in Social Networks , 2001 .

[250]  G. Gimpl,et al.  The oxytocin receptor system: structure, function, and regulation. , 2001, Physiological reviews.

[251]  R B Williams,et al.  Characteristics of Socially Isolated Patients With Coronary Artery Disease Who Are at Elevated Risk for Mortality , 2001, Psychosomatic medicine.

[252]  Alessandro Vespignani,et al.  Epidemic dynamics and endemic states in complex networks. , 2001, Physical review. E, Statistical, nonlinear, and soft matter physics.

[253]  M. Tejeda,et al.  MULTIDIMENSIONAL FAMILY THERAPY FOR ADOLESCENT DRUG ABUSE: RESULTS OF A RANDOMIZED CLINICAL TRIAL , 2001, The American journal of drug and alcohol abuse.

[254]  P. Sawchenko,et al.  Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse , 2000, The Journal of comparative neurology.

[255]  K. Uvnäs-Moberg,et al.  Plasma oxytocin levels in female fibromyalgia syndrome patients , 2000, Zeitschrift für Rheumatologie.

[256]  A. Markou,et al.  Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats , 2000, Psychopharmacology.

[257]  Carmen M. Reinhart,et al.  Fear of Floating , 2000, NursingLife.

[258]  Chao-you Song,et al.  Chronic morphine treatment inhibits oxytocin synthesis in rats , 2000, Neuroreport.

[259]  Paul Guyer,et al.  Critique of the Power of Judgment , 2000 .

[260]  Christopher D. Carroll,et al.  Saving and Growth with Habit Formation , 2000 .

[261]  A. Mino,et al.  Inpatient opiate detoxification in Geneva: follow-up at 1 and 6 months. , 2000, Drug and alcohol dependence.

[262]  Y. Shaham,et al.  Clonidine blocks stress‐induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons , 2000, The European journal of neuroscience.

[263]  S. Thomas,et al.  Alcoholics with and without social phobia: a comparison of substance use and psychiatric variables. , 1999, Journal of studies on alcohol.

[264]  C. Martin,et al.  Diagnostic orphans: adolescents with alcohol symptom who do not qualify for DSM-IV abuse or dependence diagnoses. , 1999, The American journal of psychiatry.

[265]  K. Brady,et al.  Gender differences in substance use disorders. , 1999, The Psychiatric clinics of North America.

[266]  H. Curran,et al.  Additional methadone increases craving for heroin: a double-blind, placebo-controlled study of chronic opiate users receiving methadone substitution treatment. , 1999, Addiction.

[267]  W. Newey,et al.  Nonparametric estimation of triangular simultaneous equations models , 1999 .

[268]  Samuel Fleischacker.  A third concept of liberty , 1999 .

[269]  Stephen Bond,et al.  GMM Estimation with persistent panel data: an application to production functions , 1999 .

[270]  M. Liebowitz,et al.  Psychometric properties of the Liebowitz Social Anxiety Scale , 1999, Psychological Medicine.

[271]  S. Porges.  LOVE: AN EMERGENT PROPERTY OF THE MAMMALIAN AUTONOMIC NERVOUS SYSTEM , 1998, Psychoneuroendocrinology.

[272]  G. Kovacs,et al.  OXYTOCIN AND ADDICTION: A REVIEW , 1998, Psychoneuroendocrinology.

[273]  G. Calvo,et al.  Capital Flows and Capital-Market Crises: The Simple Economics of Sudden Stops , 1998 .

[274]  K. Uvnäs‐Moberg,et al.  OXYTOCIN MAY MEDIATE THE BENEFITS OF POSITIVE SOCIAL INTERACTION AND EMOTIONS 1 The purpose of this paper is to describe the neuroendocrine mechanisms of positive social interactions. 1 , 1998, Psychoneuroendocrinology.

[275]  S. Hall,et al.  Superior efficacy of cognitive-behavioral therapy for urban crack cocaine abusers: main and matching effects. , 1998, Journal of consulting and clinical psychology.

[276]  B. Rounsaville,et al.  Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts. , 1998, Drug and alcohol dependence.

[277]  L. Marsch.  The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. , 1998, Addiction.

[278]  P. Vaglum,et al.  Psychopathology, treatment completion and 5 years outcome. A prospective study of drug abusers. , 1998, Journal of substance abuse treatment.

[279]  G. Koob,et al.  Neurobiological Similarities in Depression and Drug Dependence: A Self-Medication Hypothesis , 1998, Neuropsychopharmacology.

[280]  Randomized Trial of Cognitive‐Behavioral Therapy , 1998 .

[281]  M. Connor,et al.  How opioids inhibit GABA-mediated neurotransmission , 1997, Nature.

[282]  D. Simpson,et al.  Drug abuse treatment process components that improve retention. , 1997, Journal of substance abuse treatment.

[283]  Christopher D. Carroll,et al.  Comparison Utility in a Growth Model , 1997 .

[284]  G. Di Chiara,et al.  Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. , 1997, Science.

[285]  G. Koob,et al.  Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. , 1997, Science.

[286]  F Weiss,et al.  Ethanol Self-Administration Restores Withdrawal-Associated Deficiencies in Accumbal Dopamine and 5-Hydroxytryptamine Release in Dependent Rats , 1996, The Journal of Neuroscience.

[287]  A. Steiger,et al.  290. Nocturnal oxytocin secretion is reduced in major depression , 1996, Biological Psychiatry.

[288]  T. Roth,et al.  Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young Adults , 1996, Biological Psychiatry.

[289]  B. Mayer-Hubner.  Pseudotumour cerebri from intranasal oxytocin and excessive fluid intake , 1996, The Lancet.

[290]  D. Swaab,et al.  Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. , 1996, Archives of general psychiatry.

[291]  M. Jurzak,et al.  A new tritiated oxytocin receptor radioligand—Synthesis and application for localization of central oxytocin receptors , 1995, Peptides.

[292]  L. Parsons,et al.  Extracellular serotonin is decreased in the nucleus accumbens during withdrawal from cocaine self-administration , 1995, Behavioural Brain Research.

[293]  K. Kobak,et al.  Reliability and Validity of the Hamilton Depression Inventory: A Paper-and-Pencil Version of the Hamilton Depression Rating Scale Clinical Interview , 1995 .

[294]  M. Altemus,et al.  Suppression of hypothalmic-pituitary-adrenal axis responses to stress in lactating women. , 1995, The Journal of clinical endocrinology and metabolism.

[295]  L H Parsons,et al.  Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. , 1995, The Journal of pharmacology and experimental therapeutics.

[296]  H. A. Montgomery,et al.  Does Alcoholics Anonymous involvement predict treatment outcome? , 1995, Journal of substance abuse treatment.

[297]  R. Kaestner.  The Effects of Cocaine and Marijuana Use on Marriage and Marital Stability , 1995 .

[298]  G. Aston-Jones,et al.  Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome , 1994, Nature.

[299]  H. Nicholson,et al.  Neuroendocrine and clinical effects of electroconvulsive therapy and their relationship to treatment outcome , 1994, Psychological Medicine.

[300]  D J Rohsenow,et al.  Alcohol cue reactivity and mood induction in male and female alcoholics. , 1994, Journal of studies on alcohol.

[301]  J. Galí,et al.  Keeping Up with the Joneses: Consumption Externalities, Portfolio Choice, and Asset Prices , 1994 .

[302]  K. Brady,et al.  Anxiety and Mood Disorders in Hospitalized Alcoholic Individuals , 1992 .

[303]  J. Russell,et al.  Oxytocin and vasopressin release in discrete brain areas after naloxone in morphine-tolerant and -dependent anesthetized rats: push-pull perfusion study , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[304]  R. North,et al.  Opioids excite dopamine neurons by hyperpolarization of local interneurons , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[305]  D. Pow,et al.  Widespread release of peptides in the central nervous system: Quantitation of tannic acid‐captured exocytoses , 1991, The Anatomical record.

[306]  J. Russell,et al.  Release of Oxytocin into Blood and into Cerebrospinal Fluid Induced by Naloxone in Anaesthetized Morphine‐Dependent Rats: The Role of the Paraventricular Nucleus , 1991, Journal of neuroendocrinology.

[307]  F. Loup,et al.  Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study , 1991, Brain Research.

[308]  G. Leng,et al.  Morphine actions on supraoptic oxytocin neurones in anaesthetized rats: tolerance after i.c.v. morphine infusion. , 1991, The Journal of physiology.

[309]  S. Lightman,et al.  Psychological stress of exposure to uncontrollable noise increases plasma oxytocin in high emotionality women , 1990, Psychoneuroendocrinology.

[310]  G. Aghajanian,et al.  Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[311]  D. Nutt,et al.  Oxytocin and vasopressin responses to ECT , 1990, Psychiatry Research.

[312]  Andrew B. Abel,et al.  Asset Prices Under Habit Formation and Catching Up with the Joneses , 1990 .

[313]  T. Kamarck,et al.  Social support reduces cardiovascular reactivity to psychological challenge: a laboratory model. , 1990, Psychosomatic medicine.

[314]  J. B. Justice,et al.  Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis , 1989, Pharmacology Biochemistry and Behavior.

[315]  F. Loup,et al.  Localization of oxytocin binding sites in the human brainstem and upper spinal cord: an autoradiographic study , 1989, Brain Research.

[316]  J. Krueger,et al.  Corticotropin-releasing factor attenuates interleukin 1-induced sleep and fever in rabbits. , 1989, The American journal of physiology.

[317]  M. Gossop,et al.  Circumstances Surrounding the Initial Lapse to Opiate Use Following Detoxification , 1989, British Journal of Psychiatry.

[318]  Z. Sarnyai,et al.  Endogenous oxytocin inhibits morphine tolerance through limbic forebrain oxytocin receptors , 1988, Brain Research.

[319]  J. Jemmott,et al.  Academic stress, social support, and secretory immunoglobulin A. , 1988, Journal of personality and social psychology.

[320]  R. Lucas.  On the Mechanics of Economic Development , 1988 .

[321]  C. Roehrig,et al.  Conditions for Identification in Nonparametric and Parametic Models , 1988 .

[322]  G. Leng,et al.  Naloxone excites oxytocin neurones in the supraoptic nucleus of lactating rats after chronic morphine treatment. , 1988, The Journal of physiology.

[323]  G. Kovacs,et al.  Microinjection of oxytocin into limbic-mesolimbic brain structures disrupts heroin self-administration behavior: a receptor-mediated event? , 1987, Life sciences.

[324]  Richard F. Teichgraeber.  ‘Less Abused than I had Reason to Expect’: The Reception of The Wealth of Nations in Britain, 1776–90 , 1987, The Historical Journal.

[325]  G. Kovacs,et al.  Effects of oxytocin-related peptides on acute morphine tolerance: opposite actions by oxytocin and its receptor antagonists. , 1987, The Journal of pharmacology and experimental therapeutics.

[326]  J. Macdonald.  Predictors of treatment outcome for alcoholic women. , 1987, The International journal of the addictions.

[327]  Jennings Bryant,et al.  SHIFTING PREFERENCES IN PORNOGRAPHY CONSUMPTION , 1986 .

[328]  P. Romer.  Increasing Returns and Long-Run Growth , 1986, Journal of Political Economy.

[329]  B. Rounsaville,et al.  A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. , 1986, Archives of general psychiatry.

[330]  A. Washton.  Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors , 1986 .

[331]  C. Kovacs,et al.  Behaviorally active oxytocin fragments simultaneously attenuate heroin self-administration and tolerance in rats. , 1985, Life sciences.

[332]  T. Wills,et al.  Stress, social support, and the buffering hypothesis. , 1985, Psychological bulletin.

[333]  G. Kovacs,et al.  Oxytocin reduces intravenous heroin self-administration in heroin-tolerant rats. , 1985, Life sciences.

[334]  M. Faludi,et al.  Oxytocin and a C-terminal derivative (Z-prolyl-d-leucine) attenuate tolerance to and dependence on morphine and interact with dopaminergic neurotransmission in the mouse brain , 1985, Neuropharmacology.

[335]  M. W. Linn,et al.  Effects of unemployment on mental and physical health. , 1985, American journal of public health.

[336]  George A. Parks,et al.  Social determinants of alcohol consumption: the effects of social interaction and model status on the self-administration of alcohol. , 1985, Journal of consulting and clinical psychology.

[337]  G. Kovacs,et al.  Effects of oxytocin and a derivative (Z-prolyl-d-leucine) on morphine tolerance/withdrawal are mediated by the limbic system , 1984, Behavioural Brain Research.

[338]  W. Vale,et al.  Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF). , 1984, The Journal of pharmacology and experimental therapeutics.

[339]  D. Greenblatt,et al.  Comparative hypnotic effects of flurazepam, triazolam, and placebo: a long-term simultaneous nighttime and daytime study. , 1984, Journal of clinical psychopharmacology.

[340]  J. Kiecolt-Glaser,et al.  Psychosocial Modifiers of Immunocompetence in Medical Students , 1984, Psychosomatic medicine.

[341]  W R Martin,et al.  Pharmacology of opioids. , 1983, Pharmacological reviews.

[342]  L. Swanson,et al.  The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat , 1983, Brain Research.

[343]  G. Kovacs,et al.  Oxytocin is a precursor of potent behaviourally active neuropeptides. , 1983, European journal of pharmacology.

[344]  D. Segal,et al.  The effect of methadone on the behavioral and neuroendocrine responses of manic patients , 1982, Psychiatry Research.

[345]  P. Jones,et al.  Differential clearance of neurophysin and neurohypophysial peptides from the cerebrospinal fluid in conscious guinea pigs. , 1982, Neuroendocrinology.

[346]  M. Weissman,et al.  Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome. , 1982, Archives of general psychiatry.

[347]  F. Hegge,et al.  Acute heroin abstinence in man: IV. Sleep--waking state contingencies. , 1981, Drug and alcohol dependence.

[348]  W. Pickworth,et al.  Morphine-like insomnia from heroin in nondependent human addicts. , 1981, British journal of clinical pharmacology.

[349]  F. Goodwin,et al.  Supression of plasma cortisol in depressed patients by acute intravenous methadone infusion. , 1980, The American journal of psychiatry.

[350]  F. Hegge,et al.  Acute heroin abstinence in man: I. Changes in behavior and sleep. , 1980, Drug and alcohol dependence.

[351]  C. Vanderwende,et al.  Effect of narcotics on monoamine oxidase activity of mouse brain. , 1979, Research communications in chemical pathology and pharmacology.

[352]  A. Phillips,et al.  The role of dopamine in maintaining intracranial self-stimulation in the ventral tegmentum, nucleus accumbens, and medial prefrontal cortex. , 1978, Canadian journal of psychology.

[353]  J. Haldar,et al.  Inhibition of Oxytocin Release by Morphine and Its Analogs , 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[354]  T. C. Edens,et al.  Economic Growth , 1957, The Journal of Economic History.

[355]  Mark S. Granovetter.  The Strength of Weak Ties , 1973, American Journal of Sociology.

[356]  D. Jasinski,et al.  Physiological parameters of morphine dependence in man--tolerance, early abstinence, protracted abstinence. , 1969, Journal of psychiatric research.

[357]  Robert A. Mundell.  Capital Mobility and Stabilization Policy Under Fixed and Flexible Exchange Rates , 1963 .

[358]  K. Arrow.  The Economic Implications of Learning by Doing , 1962 .

[359]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[360]  M. Hamilton.  The assessment of anxiety states by rating. , 1959, The British journal of medical psychology.

[361]  P. Baran.  The Theory of the Leisure Class , 1957 .

[362]  P. Lazarsfeld,et al.  Personal Influence: The Part Played by People in the Flow of Mass Communications , 1956 .

[363]  J. Duesenberry,et al.  Income, Saving, and the Theory of Consumer Behavior , 1950 .

[364]  F. Ramsey,et al.  THE MATHEMATICAL THEORY OF SAVING , 1928 .

[365]  UN Office on Drugs and Crime.  World Drug Report 2019 , 2019, World Drug Report.

[366]  C. Pedersen.  Oxytocin, Tolerance, and the Dark Side of Addiction. , 2017, International review of neurobiology.

[367]  K. Tracy,et al.  Benefits of peer support groups in the treatment of addiction , 2016 .

[368]  M. Weisz.  Econometric Analysis Of Panel Data , 2016 .

[369]  E. Yeldan,et al.  The origins endogenous growth , 2016 .

[370]  E. Ozhegov.  Identification in a class of nonparametric simultaneous equation models with sample selection (in Russian) , 2015 .

[371]  Rosa L. Matzkin.  Estimation of Nonparametric Models With Simultaneity , 2015 .

[372]  Hélène Rey.  Dilemma not trilemma: the global cycle and monetary policy independence , 2013 .

[373]  David Hume,et al.  Essays, Moral, Political, And Literary , 2012 .

[374]  P. Levine,et al.  The happiness puzzle: analytical aspects of the Easterlin paradox , 2012 .

[375]  M. Brugal,et al.  Depression among regular heroin users: the influence of gender. , 2012, Addictive behaviors.

[376]  W. Pardridge.  The blood-brain barrier: Bottleneck in brain drug development , 2005, NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics.

[377]  Camille Roth,et al.  Connections: An Introduction to the Economics of Networks by Sanjeev Goyal , 2010, J. Artif. Soc. Soc. Simul..

[378]  C. Nemeroff,et al.  The CRF system, stress, depression and anxiety—insights from human genetic studies , 2010, Molecular Psychiatry.

[379]  A. Ismaila,et al.  A tutorial on pilot studies: the what, why and how , 2010, BMC medical research methodology.

[380]  R. Mattick,et al.  National clinical guidelines and procedures for the use of buprenorphine in the treatment of heroin dependence , 2009 .

[381]  J. Russell,et al.  Oxytocin (peripheral/central actions and their regulation) , 2009 .

[382]  Jason M. White,et al.  Alpha2-adrenergic agonists for the management of opioid withdrawal. , 2009, The Cochrane database of systematic reviews.

[383]  S. Bishop.  Trait anxiety and impoverished prefrontal control of attention , 2009, Nature Neuroscience.

[384]  Matthew O. Jackson,et al.  Di¤usion, Strategic Interaction, and Social Structure , 2010 .

[385]  Duncan Stewart,et al.  Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study. , 2008, Addiction.

[386]  C. Sunstein.  Republic.com 2.0 , 2007 .

[387]  Mark E. Schaffer,et al.  XTOVERID: Stata module to calculate tests of overidentifying restrictions after xtreg, xtivreg, xtivreg2, xthtaylor , 2006 .

[388]  Sue J. Wilson,et al.  Antidepressants and sleep: a qualitative review of the literature. , 2005, Drugs.

[389]  G. Koob,et al.  Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens , 2005, Psychopharmacology.

[390]  Kenneth S. Rogoff,et al.  Exchange rate regime durability and performance in developing versus advanced economies , 2005 .

[391]  M. Faludi,et al.  Oxytocin diminishes heroin tolerance in mice , 2004, Psychopharmacology.

[392]  S. Anderson,et al.  Trends and Developments , 2004 .

[393]  G. Kovacs,et al.  Limbic oxytocin and arginine8-vasopressin in morphine tolerance and dependence , 2004, Experimental Brain Research.

[394]  I. Hindmarch,et al.  The leeds sleep evaluation questionnaire in psychopharmacological investigations—a review , 2004, Psychopharmacology.

[395]  B. McEwen.  Brain-fluid barriers: relevance for theoretical controversies regarding vasopressin and oxytocin memory research. , 2004, Advances in pharmacology.

[396]  Eric Hollander,et al.  Oxytocin Infusion Reduces Repetitive Behaviors in Adults with Autistic and Asperger's Disorders , 2003, Neuropsychopharmacology.

[397]  M. Ohayon,et al.  Place of chronic insomnia in the course of depressive and anxiety disorders. , 2003, Journal of psychiatric research.

[398]  Janice C. Eberly,et al.  Competition and Innovation : An Inverted U Relationship ∗ , 2003 .

[399]  V. Chernozhukov,et al.  An IV Model of Quantile Treatment Effects , 2002 .

[400]  M. Gelkopf,et al.  Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: characteristics and a pharmacotherapeutic approach. , 2002, The Israel journal of psychiatry and related sciences.

[401]  I. Neumann.  Involvement of the brain oxytocin system in stress coping: interactions with the hypothalamo-pituitary-adrenal axis. , 2002, Progress in brain research.

[402]  R. Mattick,et al.  Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. , 2002, The Cochrane database of systematic reviews.

[403]  J. Endicott,et al.  Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH‐A) , 2001, Depression and anxiety.

[404]  E. Nunes,et al.  The effect of sertraline on methadone plasma levels in methadone-maintenance patients. , 2000, The American journal on addictions.

[405]  M Bosc,et al.  Assessment of social functioning in depression. , 2000, Comprehensive psychiatry.

[406]  M. Stitzer,et al.  Reinforcement-based intensive outpatient treatment for inner city opiate abusers: a short-term evaluation. , 2000, Drug and alcohol dependence.

[407]  M. Reivich,et al.  Limbic activation during cue-induced cocaine craving. , 1999, The American journal of psychiatry.

[408]  Kimberly Young,et al.  Cyber Disorders: The Mental Health Concern for the New Millennium , 1999, Cyberpsychology Behav. Soc. Netw..

[409]  Carol Carter Porges.  Neuroendocrine perspectives on social attachment and love , 1998 .

[410]  J. Vasterling,et al.  Attention and memory dysfunction in posttraumatic stress disorder. , 1998, Neuropsychology.

[411]  R. Brooner,et al.  Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. , 1997, Archives of general psychiatry.

[412]  Jerald G. Bachman,et al.  Smoking, Drinking, and Drug Use in Young Adulthood: The Impacts of New Freedoms and New Responsibilities , 1997 .

[413]  S. Lightman,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Central Oxytocin Administration Reduces Stress- Induced Corticosterone Release and Anxiety Behavior in Rats* , 2022 .

[414]  J. Angst,et al.  Social phobia. , 1995, European archives of psychiatry and clinical neuroscience.

[415]  P. Selwyn,et al.  Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. , 1995, American journal of public health.

[416]  M. Opp.  Corticotropin-releasing hormone involvement in stressor-induced alterations in sleep and in the regulation of waking. , 1995, Advances in neuroimmunology.

[417]  B. Lex.  Alcohol and Other Drug Abuse Among Women , 1994, Alcohol health and research world.

[418]  W R Blundell,et al.  The social contract. , 1993, Health law in Canada.

[419]  J. Powell,et al.  Anger, depression, and anxiety following heroin withdrawal. , 1992, The International journal of the addictions.

[420]  R. Watson,et al.  Cocaine use and withdrawal: the effect on sleep and mood. , 1992, The American journal of drug and alcohol abuse.

[421]  M. Stark.  Dropping out of substance abuse treatment: A clinically oriented review , 1992 .

[422]  G. Williams,et al.  The prevalence of social-evaluative anxiety in opioid users seeking treatment. , 1992, The International journal of the addictions.

[423]  J. Jaffe,et al.  Trivializing dependence. , 1990, British journal of addiction.

[424]  L. Handelsman,et al.  Two new rating scales for opiate withdrawal. , 1987, The American journal of drug and alcohol abuse.

[425]  G. Kovacs,et al.  [Effect of oxytocin microinjections into the lateral septal nucleus on intravenous heroin self-administration in heroin-tolerant rats]. , 1987, Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova.

[426]  P. Richard,et al.  Serotonergic control of oxytocin release during suckling in the rat: opposite effects in conscious and anesthetized rats. , 1983, Neuroendocrinology.

[427]  Bryan W. Brown,et al.  THE IDENTIFICATION PROBLEM IN SYSTEMS NONLINEAR IN THE VARIABLES , 1983 .

[428]  J. Buckingham.  Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides. , 1982, Neuroendocrinology.

[429]  Friedrich A. von Hayek,et al.  Law, Legislation and Liberty, Volume 2: The Mirage of Social Justice , 1977 .

[430]  Alexander Grey,et al.  The Mathematical Theory of Infectious Diseases and Its Applications , 1977 .

[431]  J. van Ree,et al.  Modulation of heroin self-administration by neurohypophyseal principles. , 1977, European Journal of Pharmacology.

[432]  W. S. Aron,et al.  Graduates and splitees from therapeutic community drug treatment programs: a comparison. , 1976, The International journal of the addictions.

[433]  D. de Wied,et al.  Prolyl-leucyl-glycinamide (PLG) facilitates morphine dependence. , 1976, Life sciences.

[434]  D. Raphael,et al.  I: The Theory of Moral Sentiments , 1976 .

[435]  P. Lazarsfeld,et al.  The People's Choice: How the Voter Makes Up His Mind in a Presidential Campaign , 1968 .

[436]  P. Lazarsfeld,et al.  Friendship as Social process: a substantive and methodological analysis , 1964 .

[437]  M. J. Keith.  Imipramine treatment. , 1960, American Journal of Psychiatry.